Human integrin β2,ITG β2/CD11+CD18 ELISA Kit

Code CSB-E10004h
Size 96T,5×96T,10×96T
See More Details 24T ELISA kits trial application
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Target Name integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
Alternative Names 95 subunit beta ELISA Kit; Beta 2 (antigen CD18 (p95) ELISA Kit; CD 18 ELISA Kit; CD18 ELISA Kit; Cell surface adhesion glycoprotein LFA 1/CR3/P150,959 beta subunit precursor) ELISA Kit; Cell surface adhesion glycoproteins LFA 1/CR3/p150,95 subunit beta ELISA Kit; Cell surface adhesion glycoproteins LFA-1/CR3/p150 ELISA Kit; Complement component 3 receptor 3 and 4 subunit ELISA Kit; Complement receptor C3 beta subunit ELISA Kit; Complement receptor C3 subunit beta ELISA Kit; Integrin beta 2 ELISA Kit; Integrin beta chain beta 2 ELISA Kit; Integrin beta-2 (ITGB2) ELISA Kit; Integrin beta-2 ELISA Kit; Integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) ELISA Kit; ITB2_HUMAN ELISA Kit; ITGB2 ELISA Kit; LAD ELISA Kit; LCAMB ELISA Kit; Leukocyte associated antigens CD18/11A, CD18/11B, CD18/11C ELISA Kit; Leukocyte cell adhesion molecule CD18 ELISA Kit; LFA 1 ELISA Kit; LFA1 ELISA Kit; Lymphocyte function associated antigen 1 (LFA1) ELISA Kit; Lymphocyte function associated antigen 1 ELISA Kit; MAC 1 ELISA Kit; MAC1 ELISA Kit; Macrophage antigen 1 (mac1) beta ELISA Kit; MF17 ELISA Kit; MFI7 ELISA Kit; OTTHUMP00000115278 ELISA Kit; OTTHUMP00000115279 ELISA Kit; OTTHUMP00000115280 ELISA Kit; OTTHUMP00000115281 ELISA Kit; OTTHUMP00000115282 ELISA Kit
Abbreviation ITGB2
Uniprot No. P05107
Species Homo sapiens (Human)
Sample Types serum, plasma, tissue homogenates
Detection Range 15.6 pg/mL-1000 pg/mL
Sensitivity 3.9 pg/mL
Assay Time 1-5h
Sample Volume 50-100ul
Detection Wavelength 450 nm
Research Area Signal Transduction
Assay Principle quantitative
Measurement Sandwich
Intra-assay Precision (Precision within an assay): CV%<8%      
Three samples of known concentration were tested twenty times on one plate to assess.  
Inter-assay Precision (Precision between assays): CV%<10%      
Three samples of known concentration were tested in twenty assays to assess.    
To assess the linearity of the assay, samples were spiked with high concentrations of human ITG β2/CD11+CD18CD18 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
  Sample Serum(n=4)  
1:1 Average % 90  
Range % 85-97  
1:2 Average % 91  
Range % 84-99  
1:4 Average % 95  
Range % 90-98  
1:8 Average % 93  
Range % 86-102  
The recovery of human ITG β2/CD11+CD18CD18 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
Sample Type Average % Recovery Range  
Serum (n=5) 95 89-98  
EDTA plasma (n=4) 96 87-100  
Typical Data
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
pg/ml OD1 OD2 Average Corrected  
1000 1.631 1.609 1.620 1.523  
500 1.365 1.318 1.342 1.245  
250 0.952 0.943 0.948 0.851  
125 0.650 0.635 0.643 0.546  
62.5 0.381 0.377 0.379 0.282  
31.2 0.267 0.259 0.263 0.166  
15.6 0.185 0.191 0.188 0.091  
0 0.095 0.099 0.097    
and FAQs
Storage Store at 2-8°C. Please refer to protocol.
Lead Time 3-5 working days

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Earn $30 Amazon Card or 20μL/μg CUSABIO Trial Size Antibody. Details of rewards >>

Target Data

Function Integrin ITGAL/ITGB2 is a receptor for ICAM1, ICAM2, ICAM3 and ICAM4. Integrins ITGAM/ITGB2 and ITGAX/ITGB2 are receptors for the iC3b fragment of the third complement component and for fibrinogen. Integrin ITGAX/ITGB2 recognizes the sequence G-P-R in fibrinogen alpha-chain. Integrin ITGAM/ITGB2 recognizes P1 and P2 peptides of fibrinogen gamma chain. Integrin ITGAM/ITGB2 is also a receptor for factor X. Integrin ITGAD/ITGB2 is a receptor for ICAM3 and VCAM1. Contributes to natural killer cell cytotoxicity
Gene References into Functions
  1. The LFA-1-ICAM-1 orientation described here with ICAM-1 pointing anti-parallel to the LFA-1 beta-subunit leg is the same orientation that would be stabilized by tensile force transmitted between the ligand and the actin cytoskeleton and is consistent with the cytoskeletal force model of integrin activation. PMID: 29507098
  2. LncRNA ITGB2-AS1 could promote the migration and invasion of breast cancer cells by up-regulating ITGB2. PMID: 29941860
  3. Overexpression of ITGB2 was not correlated with ITGB2 promoter hypomethylation in systemic sclerosis. PMID: 29356883
  4. actin engagement produces tension within the beta2 subunit to induce and stabilize an active integrin conformational state and that this requires intact talin and kindlin motifs. PMID: 27721490
  5. on tumour-infiltrating T-lymphocytes, galectin prevents the formation of a functional secretory synapse by preventing optimal LFA-1 triggering PMID: 27447355
  6. exploration of the underlying mechanism demonstrated that ICAM3 not only binds to LFA-1 with its extracellular domain and structure protein ERM but also to lamellipodia with its intracellular domain which causes a tension that pulls cells apart (metastasis). PMID: 29729315
  7. vesicle-associated RhoB is a regulator of the Rab11-mediated recycling of LFA-1 to the cell surface, an event that is necessary for T lymphocyte motility. PMID: 29233918
  8. The ITGB2 variant rs2230531 was examined in an independent cohort of Tasmanian patients with hematologic malignancies (HM) to see if its presence correlated with chronic lymphocytic leukemia. The variant was found in several lymphoid and myeloid HMs, so if contributes to the risk of HM, it does so broadly across HM subtypes in this population. PMID: 28490571
  9. an integrated strategy of whole genome and transcriptome analysis enabled identification of LB-ITGB2-1 as HLA-B*15:01-restricted MiHAs encoded by an alternative transcript. The alternative ITGB2 transcript was shown to be expressed in leukemic cells of different origins. PMID: 26964570
  10. Neutrophil rolling over E-selectin at precise shear stress transmits tension and catch-bond formation with L-selectin via sLe(x), resulting in focal clusters that deliver a distinct signal to upshift beta2-integrins to a high-affinity state. Rivipansel effectively blocked formation of selectin catch-bonds, revealing a novel mechanotransduction circuit PMID: 28811304
  11. CD177 signals in a beta2 integrin-dependent manner to orchestrate a set of activation-mediated mechanisms that impair human neutrophil migration. PMID: 28807980
  12. findings suggest the partitioning in soluble CD18 to reflect a compensatory anti-inflammatory response syndrome and hyperinflammation, respectively, manifested as part of sepsis. PMID: 28714582
  13. activation of LFA-1 (alphaLbeta2) and Mac-1 (alphaMbeta2), two subfamilies of integrin beta2 complexes, on human primary monocytes following platelet releasate treatment PMID: 27690452
  14. data suggest that regulation of LFA-1 is one reason for the different activity of NK cells during differentiation PMID: 28100681
  15. The single nucleotide polymorphism rs1143678 substitutes Pro(1146) for Ser in the integrin alphaM cytoplasmic tail generates a noncanonical 14-3-3zeta binding site that modulates integrin alphaM(PS)beta2 outside-in signaling PMID: 27974454
  16. this study shows that cross-talk between LFA-1 and Notch1 through the Akt/ERK-GSK3beta signaling enhances T cell differentiation toward Th1 PMID: 27206767
  17. The results show that with LFA-1 antibodies, we can activate LFA-1 and inhibit alpha4beta1, inhibit both LFA-1 and alpha4beta1, inhibit LFA-1 but not alpha4beta1, or not affect LFA-1 or alpha4beta1 PMID: 27443292
  18. K152 and D120 within the PH domain of SKAP55 regulate plasma membrane targeting and T cell receptor-mediated activation of LFA-1. PMID: 28052935
  19. Genetic inactivation and blockade studies revealed that homophilic interactions between intercellular adhesion molecule 1 (ICAM-1) expressed on tumor cells and MSCs, respectively, regulate the competition between tumor cells and HSPCs for binding to MSCs. Moreover, tumor cell-secreted soluble ICAM-1(sICAM-1) also impaired HSPC adhesion via blocking CD18-ICAM-1 binding between HSPCs and MSCs PMID: 27207667
  20. The ability of simvastatin to target CR3 in its ligand binding-activated conformation is a novel mechanism to explain the known anti-inflammatory effects of this compound, in particular because this CR3 conformation is found in pro-inflammatory environments. PMID: 27339893
  21. CD18 methylation and age greater than 65 years were independent prognostic factors of thrombosis complicated by primary myelofibrosis. PMID: 27595148
  22. our study highlights the difficulties with the sole use of CD18 for the diagnosis of LAD-1. PMID: 26434744
  23. genetic polymorphism is associated with leukocyte adhesion deficiency type 1 in Iranian families PMID: 26639818
  24. Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration PMID: 26498406
  25. Contact-activated C3(H2O) is a novel ligand for CD11b/CD18 that mediates platelet-PMN complex formation and the binding of platelet-derived microparticles to PMNs. PMID: 26293614
  26. The expression level of Mac-1 correlated with the number of neutrophils in patients with serous, endometrioid and undifferentiated epithelial ovarian cancer. PMID: 26563750
  27. Rerefined beta2 integrin structures show pyroglutamic acid at the beta2 N terminus and bending within the EGF1 domain. Allostery is relayed to the alphaI domain by an internal ligand binding to a pocket at the interface between the beta-propeller and betaI domains. PMID: 26936951
  28. Four new mutations in the ITGB2 gene were found. These results can be used for decisive genetic diagnosis, genetic counseling, as well as prenatal diagnosis for all patients who are suspended to Leukocyte adhesion deficiency type I (LAD-I). PMID: 26497373
  29. Contact-dependent lung adenocarcinoma aggregate dispersion by M2a macrophages occurs via ICAM-1 and beta2 integrin interactions. PMID: 26231039
  30. specific LFA-1 binding partners that may play a role in regulating LFA-1 activity in dendritic cells. PMID: 26889827
  31. The blood levels of CD18 soluble form were decreased in chronic rheumatoid arthritis patients. PMID: 26849368
  32. Data show that residues Ser745 and Ser756 in the integrin beta2 tail, which are adjacent to the NxxF motif, are required for docking protein 1, docking protein 1, 62kDa (downstream of tyrosine kinase 1) (Dok1) interaction. PMID: 26108885
  33. Gnb isoforms control a signaling pathway comprising Rac1, Plcbeta2, and Plcbeta3 leading to LFA-1 activation and neutrophil arrest in vivo PMID: 26468229
  34. Kindlin-3/FERMT3 is upregulated in atherosclerotic, mainly in cells of monocytic origin and of M2 type. Simultaneous upregulation of ITGB2 suggests a synergistic effect on leukocyte adherence and transmigration into the vessel wall. PMID: 26188538
  35. The mechanism responsible for this negative regulation exerted by CD9 on LFA-1 adhesion does not involve changes in the affinity state of this integrin but seems to be related to alterations in its state of aggregation. PMID: 26003300
  36. Case Report: recurrent pyoderma gangrenosum and cystic acne associated with leucocyte adhesion deficiency due to novel mutations in ITGB2 successfully treated with infliximab/adalimumab. PMID: 24995649
  37. Nine novel mutations in CD18 in 15 patients and 11 known mutations in 16 patients with leukocyte adhesion deficiency-I were detected. PMID: 25703682
  38. Stable clutch formation was observed for Mn(2+)-induced high affinity LFA-1, but was not required for physiological adhesion PMID: 26143530
  39. TL1A increases expression of CD25, LFA-1, CD134 and CD154, and induces IL-22 and GM-CSF production from effector CD4 T-cells PMID: 25148371
  40. Priming by CCL21 restricts lateral mobility of the adhesion receptor LFA-1 and restores adhesion to ICAM-1 nanoaggregates on human mature dendritic cells. PMID: 24945611
  41. 16 novel missense mutations in the beta2 integrin subunit have been characterized. PMID: 25514840
  42. In addition to LFA-1, this work reveals a second surface protein, Fas, that is critical for LtxA-mediated cell death. PMID: 25850729
  43. CD18 expression correlated positively with eosinophil numbers in the esophagus of patients with eosinophilic esophagitis. PMID: 24870064
  44. the coordinated expression of LFA-1 and DNAM-1 is a central component of NK cell education and provides a potential mechanism for controlling cytotoxicity by functionally mature NK cells. PMID: 25825444
  45. A signaling network stimulated by beta2 integrin promotes the polarization of lytic granules in cytotoxic cells. PMID: 25292215
  46. The positive correlation is established between content of polymorphic nuclear monocytes and level of expression of molecules of LFA-1, ICAM-1, LFA-3, and PECAM-1. PMID: 25884075
  47. The level of LFA-1 expression on allergic asthma patient peripheral blood mononuclear cells (PBMCs) was greater than on healthy PBMCs. PMID: 25341726
  48. The data provide direct support for a model in which the T cell actin network generates mechanical forces that regulate LFA-1 activity at the immunological synapse. PMID: 25666810
  49. Our results showed that alphaLbeta2 with alphaM calf-1 domain completely lost the response to Mg/EGTA activation. PMID: 25640842
  50. PTPRG is a JAK2 phosphatase that negatively regulates leukocyte integrin beta2 activation. PMID: 25624455

Show More

Hide All

Involvement in disease Leukocyte adhesion deficiency 1 (LAD1)
Subcellular Location Cell membrane, Single-pass type I membrane protein, Membrane raft, Single-pass type I membrane protein
Protein Families Integrin beta chain family
Tissue Specificity Leukocytes (PubMed:23775590). Expressed in neutrophils (at protein level) (PubMed:21193407, PubMed:28807980).
Database Links

HGNC: 6155

OMIM: 116920

KEGG: hsa:3689

STRING: 9606.ENSP00000303242

UniGene: Hs.375957


Get all the latest information on Events, Sales and Offers. Sign up for newsletter today.

© 2007-2020 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1